You just read:

Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell Carcinoma or Melanoma

News provided by

Alkermes plc

12 Jun, 2019, 12:00 BST